0
(Adds details on price in paragraph 6) By Siddhi Mahatole and Sriparna Roy Nov 12 (Reuters) – Takeda said on Thursday its narcolepsy pill, the first treatment to target the underlying cause of the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)